Phase I single- and multiple-dose escalation study of ARRY 614 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 20 Apr 2009
At a glance
- Drugs Pexmetinib (Primary)
- Indications Cancer; Rheumatoid arthritis
- Focus Adverse reactions; Biomarker
- 01 Mar 2009 Status changed from not yet recruiting to completed.
- 08 Apr 2008 New trial record.